和元生物(688238.SH)：前三季度净亏损1.62亿元

Core Viewpoint - He Yuan Biological (688238.SH) reported a decline in total operating revenue for the first three quarters of 2025, alongside a significant reduction in net loss compared to the previous year [1] Financial Performance - Total operating revenue for the first three quarters of 2025 reached 180 million yuan, representing a year-on-year decrease of 1.91% [1] - The net profit attributable to shareholders of the parent company was -162 million yuan, which is a reduction in loss by 27.65 million yuan compared to the same period last year [1] - Basic earnings per share stood at -0.254 yuan [1]